Fundz

IDRx Appoints Dr. David P. Kerstein as Chief Medical Officer

PRIVATEMar 27, 2024

Position

Chief Medical Officer

Company

IDRx

David P. Kerstein
david.kerstein@idrx.com
PlymouthBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

IDRx, Inc has appointed David P. Kerstein as Chief Medical Officer.

Quick answer

IDRx Appoints Dr. David P. Kerstein as Chief Medical Officer (March 27, 2024). IDRx is based in Plymouth, Massachusetts, United States.

Who is the new Chief Medical Officer at IDRx?
IDRx named David P. Kerstein Chief Medical Officer, announced March 27, 2024.
What did IDRx announce on March 27, 2024?
IDRx, Inc has appointed David P. Kerstein as Chief Medical Officer.
What does IDRx do?
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies.
Where is IDRx based?
IDRx is based in Plymouth, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Aculys Pharma (April 1, 2024), Ratio Therapeutics (April 2, 2024), Acadia Pharmaceuticals (April 2, 2024) and Fulcrum Therapeutics (March 18, 2024) also announced leadership changes within 45 days of IDRx.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at IDRx, and when

A new leader at IDRx brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day IDRx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at IDRx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at IDRx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

IDRx

Location

Plymouth, Massachusetts, United States

About

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. Inspired by a few curative combination regimens in cancer and the successful drug cocktails purposely engineered in other disease areas such as cystic fibrosis and antivirals, IDRx aims to address the limitations of today’s precision cancer medicines with highly selective, engineered drug combinations to stop key tumor escape mechanisms and prolong response to therapy. IDRx’s pipeline programs include small molecule tyrosine kinase inhibitors, IDRX-42 and IDRX-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). Founded in 2021, IDRx’s leadership team has extensive experience in drug development and collectively has been involved in the discovery, development and commercialization of more than 10 approved drugs. To learn more, please visit www.idrx.com and follow us on LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment IDRx changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Tim
Likely contact at this company
••••••••@••••••••

See Tim's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for IDRx's next move

Learn about Strategic plan

IDRx changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.